Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului
Yüklə 4,39 Mb.
|
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA01 CICLOSPORINUM CAPS. MOI 100 mg EQUORAL(R) 100 mg 100 mg IVAX-PHARMACEUTICALS S.R.O.
L04AA01 CICLOSPORINUM SOL. ORALĂ 100 mg/ml EQUORAL(R) 100 mg/ml IVAX-PHARMACEUTICALS S.R.O. SANDIMMUN NEORAL(R) 100 mg/ml NOVARTIS PHARMA GMBH L04AA01 CICLOSPORINUM CAPS. MOI 25 mg CICLORAL(R) HEXAL(R) 25 mg 25 mg HEXAL AG EQUORAL(R) 25 mg 25 mg IVAX-PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 25 mg NOVARTIS PHARMA GMBH L04AA01 CICLOSPORINUM CAPS. MOI 50 mg CICLORAL(R) HEXAL 50 mg 50 mg HEXAL AG EQUORAL(R) 50 mg 50 mg IVAX-PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 50 mg NOVARTIS PHARMA GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 548 |L04AX01| AZATHIOPRINUM* | Protocol: L029N | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AX01 AZATHIOPRINUM COMPR. FILM. 50 mg IMURAN(R) 50 mg THE WELLCOME FOUNDATION LTD.
________________________________________________________________________________ ______________________________________________________________________________ | 549 |V06DDN1| AMINOACIZI INCLUSIV COMBINAŢII CU | Protocol: V004N | | | | POLIPEPTIDE** | | |_______|_______|____________________________________________|_________________| ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ V06DDN1 AMINOACIZI INCLUSIV COMPR. FILM. COMBINAŢII CU POLIPEPTIDE KETOSTERIL(R) FRESENIUS KABI DEUTSCHLAND GMBH
________________________________________________________________________________ SUBLISTA C1 - G26 GLAUCOM. ______________________________________________________________________________ | 550 |S01EC03| DORZOLAMIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01EC03 DORZOLAMIDUM SOL. OFT. 20 mg/ml TRUSOPT 20 mg/ml MERCK SHARP & DOHME S.R.L ________________________________________________________________________________ ______________________________________________________________________________ | 551 |S01EC04| BRINZOLAMIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01EC04 BRINZOLAMIDUM PICĂTURI OFT. - SUSP. 10 mg/ml AZOPT 10 mg/ml 10 mg/ml ALCON LABORATORIES LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 552 |S01ED01| TIMOLOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01ED01 TIMOLOLUM PICĂTURI OFT. - SOL 0.25% TIMO-COMOD(R) 0.25% URSAPHARM ARZNEIMITTEL GMBH&CO.KG TIMOLOL 0.25% 0.25% E.I.P.I. CO. MED S.R.L
TIMO-COMOD(R) 0.5% URSAPHARM ARZNEIMITTEL GMBH&CO.KG TIMO-GAL(R) 0.5% TERAPIA SA TIMOLOL 0.5% 0.5% E.I.P.I.CO. MED S.R.L.
NYOLOL GEL 1 mg/g NOVARTIS PHARMA GMBH S01ED01 TIMOLOLUM PIC. OFT. - SOL. 2.5 mg/ml TIMOPTIC 2.5 mg/ml MERCK SHARP & DOHME ROMANIA S.R.L.
ARUTIMOL 0.25% 2.5 mg/ml CHAUVIN ANKERPHARM GMBH S01ED01 TIMOLOLUM PIC. OFT. - SOL. 5 mg/ml TIMOPTIC 5 mg/ml MERCK SHARP & DOHME ROMANIA S.R.L.
ARUTIMOL 0.5% 5 mg/ml CHAUVIN ANKERPHARM GMBH S01ED01 TIMOLOLUM PIC. OFT., SOL. 2.5 mg/ml TIMOLOL RPH 0.25% 2.5 mg/ml ROMPHARM COMPANY SRL S01ED01 TIMOLOLUM PIC. OFT. SOL. 2.5 mg/ml TIMABAK 2,5 mg/ml 2.5 mg/ml LABORATOIRES THEA S01ED01 TIMOLOLUM PIC. OFT. SOL. 5 mg/ml TIMABAK 5 mg/ml 5 mg/ml LABORATORIES THEA TIMOLOL RPH 0.5% 5 mg/ml ROMPHARM COMPANY SRL ________________________________________________________________________________ ______________________________________________________________________________ | 553 |S01ED02| BETAXOLOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01ED02 BETAXOLOLUM PICĂTURI OFT. - SUSP. 0.25% BETOPTIC-S 0.25% ALCON COUVREUR NV
BETAX 5 mg/ml ROMPHARM SRL S01ED02 BETAXOLOLUM PIC. OFTALMICE. SOL 5 mg/ml BETOPTIC 5 mg/ml ALCON COUVREUR NV S01ED02 BETAXOLOLUM PIC. OFT. SOL. 5 mg/ml BETAXOLOL 5 mg/ml TERAPIA SA ________________________________________________________________________________
| 554 |S01ED05| CARTEOLOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01ED05 CARTEOLOLUM PICĂTURI OFT. - SOL. 20 mg/ml CARTEOL 2% 20 mg/ml S.I.F.I. SPA
PREL
FORTINOL EP 2% 20 mg/ml DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH S01ED05 CARTEOLOLUM PICĂTURI OFT. - SOL. 2% CARTEOL 2% 2% S.I.F.I. SPA ________________________________________________________________________________
| 555 |S01ED51| COMBINAŢII (BIMATOPROSTUM + TIMOLOLUM) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01ED51 COMBINAŢII PIC. OFT.. SOL. 300 µg/ml + 5 mg/ml (BIMATOPROSTUM + TIMOLOLUM) GANFORT 300 µg/ml + 5 mg/ml ALLERGAN PHARMACEUTICALS IRELAND
________________________________________________________________________________ ______________________________________________________________________________ | 556 |S01ED51| COMBINAŢII (DORZOLAMIDUM + TIMOLOLUM) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01ED51 COMBINAŢII PIC. OFT. - SOL. (DORZOLAMIDUM + TIMOLOLUM) COSOPT FĂRĂ MERCK SHARP & DOHME CONCENTRAŢIE ________________________________________________________________________________
| 557 |S01ED51| COMBINAŢII (LATANOPROSTUM + TIMOLOLUM) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01ED51 COMBINAŢII SOL. OFT. (LATANOPROSTUM + TIMOLOLUM) XALCOM(R) FĂRĂ PFIZER EUROPE MA EEI CONCENTRAŢIE ________________________________________________________________________________
| 558 |S01EE01| LATANOPROSTUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01EE01 LATANOPROSTUM PICĂTURI OFT. - SOL. 5,00% XALATAN(R) 0.005% PFIZER EUROPE MA EEIG ________________________________________________________________________________ ______________________________________________________________________________ | 559 |S01EE03| BIMATOPROSTUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01EE03 BIMATOPROSTUM PIC. OFT. SOL. 0,3 mg/ml LUMIGAN 0,3 mg/ml 0.3 mg/ml ALLERGAN PHARMACEUTICALS IRELAND
________________________________________________________________________________ ______________________________________________________________________________ | 561 |S01EE04| TRAVOPROSTUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01EE04 TRAVOPROSTUM PICĂTURI OFT. SOL. 40 µg/ml TRAVATAN 40 µg/ml 40 µg/ml ALCON LABORATORIES LTD. ________________________________________________________________________________ SUBLISTA C1 - G27 PEMFIGUS. ______________________________________________________________________________ | 562 |H02AB02| DEXAMETHASONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H02AB02 DEXAMETHASONUM SOL. INJ. 8 mg DEXAMETHASONE SODIUM 8 mg E.I.P.I.CO. MED S.R.L PHOSPHATE H02AB02 DEXAMETHASONUM SOL. INJ. 8 mg/2 ml DEXAMED 8 mg/2 ml MEDOCHEMIE LTD. ________________________________________________________________________________
| 563 |H02AB04| METHYLPREDNISOLONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H02AB04 METHYLPREDNISOLONUM H02AB04 METHYLPREDNISOLONUM COMPR. MEDROL 32 32 mg PFIZER EUROPE MA EEI H02AB04 METHYLPREDNISOLONUM COMPR. MEDROL 4 mg 4 mg PFIZER EUROPE MA EEI H02AB04 METHYLPREDNISOLONUM COMPR. MEDROL A 16 16 mg PFIZER EUROPE MA EEI H02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.
SOLU-MEDROL 500 mg/7,8 ml 500 mg/7.8 ml PFIZER EUROPE MA EEI H02AB04 METHYLPREDNISOLONUM LIOF. ŞI SOLV. PT. SOL. INJ.
SOLU-MEDROL ACT-O-VIAL 125 mg/2 ml PFIZER EUROPE MA EEI H02AB04 METHYLPREDNISOLONUM LIOF. ŞI SOLV. PT. SOL. INJ.
SOLU-MEDROL ACT-O- VIAL 250 mg/4 ml PFIZER EUROPE MA EEI H02AB04 METHYLPREDNISOLONUM LIOF. ŞI SOLV. PT. SOL. INJ.
SOLU-MEDROL ACT-O-VIAL 40 mg/1 ml PFIZER EUROPE MA EEI H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. LEMOD SOLU 125 mg 125 mg HEMOFARM S.R.L. H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. LEMOD SOLU 40 mg 40 mg HEMOFARM S.R.L. H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. LEMOD SOLU 20 mg 20 mg HEMOFARM S.R.L. H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. LEMOD SOLU 500 mg 500 mg HEMOFARM S.R.L. ________________________________________________________________________________
| 564 |H02AB07| PREDNISONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H02AB07 PREDNISONUM COMPR. 5 mg N-PREDNISON 5 mg MEDUMAN SA PREDNISON 5 mg 5 mg SINTOFARM SA PREDNISON ARENA 5 mg 5 mg ARENA GROUP SA PREDNISON GEDEON RICHTER 5 mg 5 mg GEDEON RICHTER ROMANIA SA PREDNISON MAGISTRA 5 mg 5 mg MAGISTRA C & C ________________________________________________________________________________ ______________________________________________________________________________ | 565 |J04BA02| DAPSONUM (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J04BA02 DAPSONUM ________________________________________________________________________________
| 566 |L01AA01| CYCLOPHOSPHAMIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./ 1 g PERF. ENDOXAN(R) 1 g 1 g BAXTER ONCOLOGY GMBH L01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. PERF./ 200 mg INJ. I.V. ENDOXAN 200 mg 200 mg ACTAVIS S.R.L.
PERF.
ENDOXAN(R) 500 mg 500 mg BAXTER ONCOLOGY GMBH L01AA01 CYCLOPHOSPHAMIDUM DRAJ. 50 mg ENDOXAN(R) 50 mg 50 mg BAXTER ONCOLOGY GMBH ________________________________________________________________________________
| 568 |L04AA01| CICLOSPORINUM* | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA01 CICLOSPORINUM CAPS. MOI 100 mg EQUORAL(R) 100 mg 100 mg IVAX-PHARMACEUTICALS S.R.O.
EQUORAL(R) 100 mg/ml IVAX-PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 100 mg/ml NOVARTIS PHARMA GMBH L04AA01 CICLOSPORINUM CAPS. MOI 25 mg CICLORAL(R) HEXAL(R) 25 mg 25 mg HEXAL AG EQUORAL(R) 25 mg 25 mg IVAX-PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 25 mg NOVARTIS PHARMA GMBH L04AA01 CICLOSPORINUM CAPS. MOI 50 mg CICLORAL(R) HEXAL 50 mg 50 mg HEXAL AG EQUORAL(R) 50 mg 50 mg IVAX-PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 50 mg NOVARTIS PHARMA GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 569 |L04AX01| AZATHIOPRINUM* | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AX01 AZATHIOPRINUM COMPR. FILM. 50 mg IMURAN(R) 50 mg THE WELLCOME FOUNDATION LTD.
________________________________________________________________________________ SUBLISTA C1 - G29 BOALA GAUCHER. ______________________________________________________________________________ | 570 |A16AB02| IMIGLUCERASUM**** | Protocol: A008E | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ A16AB02 IMIGLUCERASUM PULB. PT. CONC. PT. 200 U SOL. PERF. CEREZYME 200 U 200 U GENZYME EUROPE BV A16AB02 IMIGLUCERASUM PULB. PT. CONC. PT. 400 U SOL. PERF. CEREZYME 400 U 400 U GENZYME EUROPE BV ________________________________________________________________________________ ______________________________________________________________________________ | 571 |A16AX06| MIGLUSTATUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ A16AX06 MIGLUSTATUM CAPS. 100 mg ZAVESCA 100 mg ACTELION REGISTRATION LTD. ________________________________________________________________________________ SUBLISTA C1 - G30 BOLI VENERICE (SIFILIS, GONOREE, INFECŢIA CU CHLAMIDIA). ______________________________________________________________________________ | 572 |J01AA02| DOXYCYCLINUM | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01AA02 DOXYCYCLINUM CAPS. 100 mg DOXICILINA 100 mg EUROPHARM SA DOXICILINA 100 mg 100 mg ANTIBIOTICE SA DOXICICUNA SANDOZ 100 mg 100 mg SANDOZ SRL
UNIDOX SOLUTAB 100 mg ASTELLAS PHARMA EUROPE B.V.
DOXICILINA 100 mg ARENA GROUP SA DOXICILINA 100 mg 100 mg ANTIBIOTICE SA DOXICILINA SANDOZ 100 mg 100 mg SANDOZ SRL J01AA02 DOXYCYCLINUM COMPR. DISP. 100 mg UNIDOX SOLUTAB 100 mg ASTELLAS PHARMA EUROPE B.V.
DOXICICLINA 100 mg ARENA GROUP SA DOXICICLINA 100 mg 100 mg ANTIBIOTICE SA DOXICICLINA SANDOZ 100 mg 100 mg SANDOZ SRL J01AA02 DOXYCYCLINUM COMPR. DISP. 100 mg UNIDOX SOLUTAB 100 mg ASTELLAS PHARMA EUROPE B.V. ________________________________________________________________________________ ______________________________________________________________________________ | 573 |J01AA07| TETRACYCLINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01AA07 TETRACYCLINUM CAPS. 250 mg TETRACICLINA 250 mg 250 mg ANTIBIOTICE SA TETRACICLINA SANDOZ 250 mg 250 mg SANDOZ SRL ________________________________________________________________________________
| 574 |J01CE02| PHENOXYMETHYLPENICILLINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01CE02 COMPR. 1000000 ui PHENOXYMETHYLPENICILLINUM PENICILINA V 1 000 000 U.I. 1000000 ui EUROPHARM SA J01CE02 COMPR. FILM. 1000000 ui PHENOXYMETHYLPENICILLINUM OSPEN(R) 1000 1000000 ui SANDOZ GMBH
PHENOXYMETHYLPENICILLINUM OSPEN(R) 1500 1500000 ui SANDOZ GMBH
PHENOXYMETHYLPENICILLINUM OSPEN 400 400000 ui/5 ml SANDOZ GMBH
PHENOXYMETHYLPENICILLINUM OSPEN(R) 500 500000 ui SANDOZ GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 575 |J01CE01| BENZYLPENICILLINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ. 1000000 ui PENICILINA G SODICA 1000000 ui ANTIBIOTICE SA
PENICILINA G POTASICA 1000000 ui ANTIBIOTICE SA J01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ. 400000 ui PENICILINA G SODICA 400000 ui ANTIBIOTICE SA J01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ. 400000 ui PENICILINA G POTASICA 400000 ui ANTIBIOTICE SA ________________________________________________________________________________
| 576 |J01CE08| BENZATHINI BENZYLPENICILLINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01CE08 BENZATHINI PULB. PT. SUSP. INJ. 1200000 ui BENZYLPENICILLINUM MOLDAMIN(R) 1200000 ui ANTIBIOTICE SA J01CE08 BENZATHINI PULB. PT. SUSP. INJ. 600000 ui BENZYLPENICILLINUM MOLDAMIN(R) 600000 ui ANTIBIOTICE SA ________________________________________________________________________________ ______________________________________________________________________________ | 577 |J01DD08| CEFIXIMUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01DD08 CEFIXIMUM GRAN. PT. SUSP. ORALĂ 100 mg/5ml SUPRAX 100 mg/5 ml GEDEON RICHTER LTD.
EFICEF(R) 200 mg 200 mg ANTIBIOTICE SA J01DD08 CEFIXIMUM COMPR. FILM. 200 mg SUPRAX 200 mg GEDEON RICHTER LTD. ______________________________________________________________________________ | 578 |J01FA01| ERYTHROMYCINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01FA01 ERYTHROMYCINUM COMPR. 200 mg ERITROMAGIS 200 mg 200 mg ARENA GROUP SA ERITROMICINA 200 mg 200 mg ANTIBIOTICE SA ERITROMICINA EUROPHARM 200 mg 200 mg EUROPHARM SA ERITROMICINA SANDOZ 200 mg 200 mg SANDOZ S.R.L. COMPRIMATE J01FA01 ERYTHROMYCINUM PULB. PT. SUSP. ORALĂ 200 mg/5 ml ERITRO 200 200 mg/5ml LEK PHARMATECH SRL ________________________________________________________________________________ ______________________________________________________________________________ | 579 |J01FA10| AZITHROMYCINUM | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|